Longitudinal assessment of S100B serum levels and clinical factors in youth patients with mood disorders.

Scientific Reports
Aleksandra Rajewska-RagerMaria Skibinska

Abstract

Mood disorders have been discussed as being in relation to glial pathology. S100B is a calcium-binding protein, and a marker of glial dysfunctions. Although alterations in the S100B expression may play a role in various central nervous system diseases, there are no studies on the potential role of S100B in mood disorders in adolescents and young adults . In a prospective two-year follow-up study, peripheral levels of S100B were investigated in 79 adolescent/young adult patients (aged 14-24 years), diagnosed with mood disorders and compared with 31 healthy control subjects. A comprehensive clinical interview was conducted which focused on clinical symptoms and diagnosis change. The diagnosis was established and verified at each control visit. Serum S100B concentrations were determined. We detected: lower S100B levels in medicated patients, compared with those who were drug-free, and healthy controls; higher S100B levels in a depressed group with a family history of affective disorder; correlations between age and medication status; sex-dependent differences in S100B levels; and lack a of correlation between the severity of depressive or hypo/manic symptoms. The results of our study indicate that S100B might be a trait-dependent ...Continue Reading

References

Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
May 15, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R Machado-VieiraD O Souza
Sep 28, 2002·Neuroreport·Matthias L SchroeterIngolf E Blasig
Mar 20, 2003·Microscopy Research and Technique·Matthias RothermundtVolker Arolt
Jul 31, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Volker AroltMatthias Rothermundt
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
May 19, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nitin GogtayPaul M Thompson
Dec 8, 2004·Life Sciences·Rodrigo Machado-VieiraLuis Valmor C Portela
May 26, 2007·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·S RocheP McKeon
Apr 24, 2008·Journal of Affective Disorders·Matthias L SchroeterIngolf E Blasig
Jun 6, 2009·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Kun YangLin-Yan Su
Aug 24, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Kai-Ren LuoShih-Jen Tsai
Dec 15, 2010·Journal of Affective Disorders·Matthias L SchroeterKarsten Mueller
Jun 30, 2011·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Elif DagdanSiobhan Roche
Apr 4, 2013·Journal of Neuroinflammation·Souhel NajjarOrrin Devinsky
Apr 13, 2013·Neuropsychiatric Disease and Treatment·Mariam ArainSushil Sharma
May 25, 2013·Current Drug Targets·Matthias L SchroeterKarsten Mueller
Sep 13, 2013·Journal of Child and Adolescent Psychopharmacology·Nathalie BockTill Manzke
Sep 30, 2014·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Frank Martin SchmidtPeter Schönknecht
Oct 4, 2014·Behavioural Brain Research·Nina StrennAgneta Ekman
Feb 12, 2015·Journal of Psychiatric Research·Tatiana FalconeAmit Anand
Sep 14, 2015·The International Journal of Neuropsychopharmacology·Oliver AmbréeTom K Birkenhäger
Feb 6, 2016·CNS Neuroscience & Therapeutics·Yuan FangXia Li
May 17, 2018·Nordic Journal of Psychiatry·Hilda Kroksmark, Maj Vinberg
Feb 13, 2019·Indian Journal of Psychiatry·Parul AroraAsok Kumar Mukhopadhyay
Jun 5, 2019·Neuroscience and Biobehavioral Reviews·Frederieke A J GigaseLot D de Witte
Mar 17, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Francesco BartoliGiuseppe Carrà
Jul 16, 2020·Journal of Affective Disorders·Ninja Meinhard OttesenMaj Vinberg
Sep 28, 2020·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Yachen ShiZhijun Zhang

❮ Previous
Next ❯

Citations

Dec 3, 2021·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Umit TuralDan Vlad Iosifescu

❮ Previous
Next ❯

Software Mentioned

DuoSet
R
Statistica

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Drug Targets
Matthias L SchroeterKarsten Mueller
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics
Christa HohoffMatthias Rothermundt
© 2021 Meta ULC. All rights reserved